We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




DiagnoCure Acquires Samba Technologies

By HospiMedica staff writers
Posted on 08 Jan 2004
Print article
In a move to insure its future growth, DiagnoCure (Quebec City, Canada) has acquired the assets, customer lists, and intellectual property of Samba Technologies SARL (France).

The intellectual property includes digital imaging and information technology that will help DiagnoCure create new applications in cancer diagnostic immunoassays. Digital imaging is necessary for the automation of immunopathology assays, a requirement for clinical laboratories performing large-volume testing. Prior to the acquisition, Samba had been a partner with DiagnoCure in the automation of its bladder cancer immunoassay, ImmunCyt/uCyt+. Samba's products are currently found in cancer centers and pathology reference laboratories throughout Europe and North America.

No financial details were disclosed. In November 2003, DiagnoCure gave an exclusive worldwide license to Gen-Probe to use its PCA3 (DD3) technology in prostate cancer.

DiagnoCure specializes in the development, production, and commercialization of diagnostic tests for detecting cancer. Currently, the company is actively pursuing the development of a prototype test for lung cancer detection.




Related Links:
DiagnoCure
Samba
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Histamine ELISA
Histamine ELISA
New
Anti-Secukinumab ELISA
LISA-TRACKER anti-Secukinumab

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.